Natural Peptides in Drug Discovery Targeting Acetylcholinesterase
AbstractAcetylcholinesterase-inhibitory peptide has gained much importance since it can inhibit acetylcholinesterase (AChE) and increase the availability of acetylcholine in cholinergic synapses, enhancing cholinergic transmission in pharmacological treatment of Alzheimer’s disease (AD). Natural peptides have received considerable attention as biologically important substances as a source of AChE inhibitors. These natural peptides have high potential pharmaceutical and medicinal values due to their bioactivities as neuroprotective and neurodegenerative treatment activities. These peptides have attracted great interest in the pharmaceutical industries, in order to design potential peptides for use in the prophylactic and therapy purposes. Some natural peptides and their derivatives have high commercial values and have succeeded in reaching the pharmaceutical market. A large number of peptides are already in preclinical and clinical pipelines for treatment of various diseases. This review highlights the recent researches on the various natural peptides and future prospects for AD management. View Full-Text
Share & Cite This Article
Prasasty, V.; Radifar, M.; Istyastono, E. Natural Peptides in Drug Discovery Targeting Acetylcholinesterase. Molecules 2018, 23, 2344.
Prasasty V, Radifar M, Istyastono E. Natural Peptides in Drug Discovery Targeting Acetylcholinesterase. Molecules. 2018; 23(9):2344.Chicago/Turabian Style
Prasasty, Vivitri; Radifar, Muhammad; Istyastono, Enade. 2018. "Natural Peptides in Drug Discovery Targeting Acetylcholinesterase." Molecules 23, no. 9: 2344.
Note that from the first issue of 2016, MDPI journals use article numbers instead of page numbers. See further details here.